MedTrace Logo

Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint

NCT01394042 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-07-14

No results posted yet for this study

Summary

This is a small study to determine if probe, similar to an ultrasound probe, can detect prostate cancer more specifically than other imaging studies in patients with a positive prostate cancer biopsy.

Conditions

Interventions

DEVICE

Proxiscan device

All patients will be imaged with the device

Sponsors & Collaborators

  • Hybridyne Imaging Technologies

    collaborator UNKNOWN

  • Radiological Associates of Sacramento Medical Group Inc.

    lead OTHER

Principal Investigators

  • Benjamin Franc, MD · Radiological Associates of Sacramento Medical Group Inc.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-12-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01394042 on ClinicalTrials.gov